Xencor XNCR
NASDAQ XNCR
$39.97 +0.58 (+1.47%)
At close: Nov 11, 2026 · 4:00 PM EST

Xencor (XNCR) Return on Sales [ROS] (2013 - 2026)

Updated

Xencor's Return on Sales [ROS] was -72.37% in Q2 2026, up 3.70 percentage points from -76.07% a year earlier and up 1651.77 percentage points from the prior quarter.

Analysis

Xencor (XNCR) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Xencor's Return on Sales [ROS] was -205.84% through Jun 30, 2026, down 107.34 percentage points year-over-year; for FY2025, it came in at -141.35%, up 20.12 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -78.76 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -161.47% in FY2024 (-85.66 pp), -75.80% in FY2023 (-25.70 pp), -50.11% in FY2022 (-66.01 pp) and 15.91% in FY2021 (+78.50 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q4 2024.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of -194.36 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2025 (a gain of 209.78 percentage points); the worst was Q1 2026 (a drop of 1592.21 percentage points).
  • Per Business Quant data, XNCR's Return on Sales [ROS] in the three quarters before Q2 2026 was -1724.14% (Q1 2026), -189.92% (Q4 2025) and -226.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Xencor 2.94 Bn 1.37 Bn - 19.62%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 19.62%
Jun 30, 2026 -72.37%
Mar 31, 2026 -1,724.14%
Dec 31, 2025 -189.92%
Sep 30, 2025 -226.29%
Jun 30, 2025 -76.07%
Mar 31, 2025 -131.93%
Dec 31, 2024 -24.96%
Sep 30, 2024 -310.17%
Jun 30, 2024 -231.61%
Mar 31, 2024 -341.71%
Dec 31, 2023 -53.67%
Sep 30, 2023 -30.86%
Jun 30, 2023 -57.11%
Mar 31, 2023 -319.71%
Dec 31, 2022 -197.19%
Sep 30, 2022 -140.47%
Jun 30, 2022 -92.72%
Mar 31, 2022 30.95%
Dec 31, 2021 59.51%
API Access

Xencor Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY